MOLLY MCGILL: Open Payments
NPI 1013252998 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,951 in 114 payments from 15 companies in 2025. Trend: 2023 $1,343 · 2024 $1,458 · 2025 $1,951
Food & beverage: $1,951
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $403 |
| ABBVIE INC. | 22 | $396 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $242 |
| GlaxoSmithKline, LLC. | 11 | $172 |
| AstraZeneca Pharmaceuticals LP | 7 | $156 |
| Amgen Inc. | 15 | $155 |
| Lilly USA, LLC | 11 | $131 |
| Exact Sciences Corporation | 5 | $82 |
| PFIZER INC. | 3 | $54 |
| Phathom Pharmaceuticals, Inc. | 2 | $44 |
Products named: Ozempic, XIFAXAN, VRAYLAR, OTEZLA, UBRELVY, TRELEGY ELLIPTA, JARDIANCE, AIRSUPRA.
Industry payments across TN — which companies pay providers there.
